Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma

BACKGROUND: The change in renal function induced by first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma remains unclear. METHODS: One hundred and thirty-four patients were evaluated. Sunitinib (SU) and sorafenib (SO) were administered to 91 (67.9%) and 43 (32.1%) patient...

全面介紹

Na minha lista:
書目詳細資料
發表在:Jpn J Clin Oncol
Main Authors: Ishihara, Hiroki, Kondo, Tsunenori, Fukuda, Hironori, Yoshida, Kazuhiko, Omae, Kenji, Takagi, Toshio, Iizuka, Junpei, Kobayashi, Hirohito, Tanabe, Kazunari
格式: Artigo
語言:Inglês
出版: Oxford University Press 2017
主題:
Original Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896698/
https://ncbi.nlm.nih.gov/pubmed/29140528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyx161
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍